Sulai Liu
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
-
- Pancreatic and Hepatic Oncology Research 9
-
- Ferroptosis and cancer prognosis 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 21
- Pancreatitis Pathology and Treatment 7
-
- Nanoplatforms for cancer theranostics 16
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Yinghui SongMasakiyo SakaguchiKen KataokaNam-ho HuhHitoshi MurataChuang PengYuhang LiLianhong Zou
- Journals
- Angewandte Chemie International Edition (2 papers)SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Sulai Liu
72 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 202
- Biological Psychiatry 17
- Molecular Biology 460
- Oncology 172
- Pulmonary and Respiratory Medicine 156
Countries citing papers authored by Sulai Liu
This map shows the geographic impact of Sulai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulai Liu more than expected).
Fields of papers citing papers by Sulai Liu
This network shows the impact of papers produced by Sulai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulai Liu. The network helps show where Sulai Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sulai Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 41 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 29 | |
| 12 | 2023 | 0 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 9 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 37 | |
| 17 | 2019 | 17 | |
| 18 | 2017 | 17 | |
| 19 | 2016 | 77 | |
| 20 | 2014 | 17 |
About Sulai Liu
Sulai Liu is a scholar working on Cancer Research, Hepatology and Surgery, having authored 83 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Nanoplatforms for cancer theranostics (16 papers), Pancreatic and Hepatic Oncology Research (9 papers), MicroRNA in disease regulation (8 papers), Pancreatitis Pathology and Treatment (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (202 citations), Biological Psychiatry (17 citations) and Molecular Biology (460 citations). Sulai Liu has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Yinghui Song, Masakiyo Sakaguchi, Ken Kataoka, Nam-ho Huh, Hitoshi Murata, Chuang Peng, Yuhang Li, Lianhong Zou, Yu Jiang and Xiehong Liu. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.